Home LiteratureArticle Details
PMID: 8618897 Published · ppublish English Journal Article

Differentiation of immortal cells inhibits telomerase activity.

Sharma HW, Sokoloski JA, Perez JR, Maltese JY, Sartorelli AC, Stein CA, Nichols G, Khaled Z, Telang NT, Narayanan R

Abstract

Telomerase, a ribonucleic acid-protein complex, adds hexameric repeats of 5'-TTAGGG-3' to the ends of mammalian chromosomal DNA (telomeres) to compensate for the progressive loss that occurs with successive rounds of DNA replication. Although somatic cells do not express telomerase, germ cells and immortalized cells, including neoplastic cells, express this activity. To determine whether the phenotypic differentiation of immortalized cells is linked to the regulation of telomerase activity, terminal differentiation was induced in leukemic cell lines by diverse agents. A pronounced downregulation of telomerase activity was produced as a consequence of the differentiated status. The differentiation-inducing agents did not directly inhibit telomerase activity, suggesting that the inhibition of telomerase activity is in response to induction of differentiation. The loss of telomerase activity was not due to the production of an inhibitor, since extracts from differentiated cells did not cause inhibition of telomerase activity. By using additional cell lineages including epithelial and embryonal stem cells, down-regulation of telomerase activity was found to be a general response to the induction of differentiation. These findings provide the first direct link between telomerase activity and terminal differentiation and may provide a model to study regulation of telomerase activity.

MeSH Terms
Animals Base Sequence Butyrates/pharmacology Butyric Acid Calcitriol/pharmacology Cell Differentiation/drug effects,physiology Cell Line Cell Nucleus/enzymology Colonic Neoplasms Cytoplasm/enzymology Dimethyl Sulfoxide/pharmacology Growth Inhibitors/pharmacology HL-60 Cells Humans Interleukin-6 Kidney Leukemia Inhibitory Factor Leukemia, Myelogenous, Chronic, BCR-ABL Positive Lymphokines/pharmacology Mice Repetitive Sequences, Nucleic Acid Stem Cells Telomerase/metabolism Teratocarcinoma Tetradecanoylphorbol Acetate/pharmacology Tretinoin/pharmacology Tumor Cells, Cultured
Chemicals
Butyrates Growth Inhibitors Interleukin-6 LIF protein, human Leukemia Inhibitory Factor Lif protein, mouse Lymphokines Butyric Acid Tretinoin Telomerase Calcitriol Tetradecanoylphorbol Acetate Dimethyl Sulfoxide
Authors & Affiliations
10 authors, click to expand affiliations / ORCID
Sharma H W
Division of Oncology, Roche Research Center, Hoffmann-La Roche Inc., Nutley, NJ 07110, USA.
Sokoloski J A
Perez J R
Maltese J Y
Sartorelli A C
Stein C A
Nichols G
Khaled Z
Telang N T
Narayanan R
References (14)
14 references, click to expand
  1. Hormonal induction of differentiation in teratocarcinoma stem cells: generation of parietal endoderm by retinoic acid and dibutyryl cAMP.
    Cell. 1980 Sep;21(2):347-55 PMID: 6250719
  2. Myeloid and megakaryocytic properties of K-562 cell lines.
    Cancer Res. 1983 Oct;43(10):4569-74 PMID: 6349795
  3. Mechanism of transcriptional activation by Sp1: evidence for coactivators.
    Cell. 1990 Jun 29;61(7):1187-97 PMID: 2194667
  4. Telomere loss: mitotic clock or genetic time bomb?
    Mutat Res. 1991 Mar-Nov;256(2-6):271-82 PMID: 1722017
  5. Evidence for differential functions of the p50 and p65 subunits of NF-kappa B with a cell adhesion model.
    Mol Cell Biol. 1993 Jun;13(6):3802-10 PMID: 8497281
  6. Antisense oligonucleotides to the p65 subunit of NF-kappa B block CD11b expression and alter adhesion properties of differentiated HL-60 granulocytes.
    Blood. 1993 Jul 15;82(2):625-32 PMID: 8101106
  7. Is telomerase a universal cancer target?
    J Natl Cancer Inst. 1995 Jun 21;87(12):859-61 PMID: 7666470
  8. Telomerase activity in germline and embryonic cells of Xenopus.
    EMBO J. 1994 Jul 1;13(13):3211-7 PMID: 8039513
  9. Telomere dynamics in an immortal human cell line.
    EMBO J. 1994 Oct 17;13(20):4953-62 PMID: 7957062
  10. Specific association of human telomerase activity with immortal cells and cancer.
    Science. 1994 Dec 23;266(5193):2011-5 PMID: 7605428
  11. Telomeres, cancer, and immortality.
    N Engl J Med. 1995 Apr 6;332(14):955-6 PMID: 7877656
  12. Telomerase activity in normal leukocytes and in hematologic malignancies.
    Blood. 1995 May 1;85(9):2315-20 PMID: 7727765
  13. Telomerase activity in human liver tissues: comparison between chronic liver disease and hepatocellular carcinomas.
    Cancer Res. 1995 Jul 1;55(13):2734-6 PMID: 7796395
  14. Antisense inhibition of the p65 subunit of NF-kappa B blocks tumorigenicity and causes tumor regression.
    Proc Natl Acad Sci U S A. 1993 Nov 1;90(21):9901-5 PMID: 8234333
Article Info
Journal
Proceedings of the National Academy of Sciences of the United States of America
Abbr.
Proc Natl Acad Sci U S A
ISSN
0027-8424
Published
1995-12-19
Pages
12343-6
Language
English
Region
United States
NLM ID
7505876
PMCID
PMC40353
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]